[Renal effects of piretanide].
Greger
R
R
Physiologisches Institut, Albert-Ludwigs-Universität, Freiburg.
D000255:Adenosine Triphosphate / Q000378:metabolism; D002352:Carrier Proteins / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007672:Kidney Cortex / Q000187:drug effects*; D007686:Kidney Tubules, Distal / Q000187:drug effects*; D008564:Membrane Potentials / Q000187:drug effects; D010477:Perfusion; D028021:Sodium-Potassium-Chloride Symporters; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000494:pharmacology*; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D002352:Carrier Proteins; D004232:Diuretics; D028021:Sodium-Potassium-Chloride Symporters; D013449:Sulfonamides; D000255:Adenosine Triphosphate; C015451:piretanide
Die renalen Effekte von Piretanid.